Valuation: Bonesupport Holding AB

Market Cap 20.45B 2.02B 1.84B 1.7B 1.53B 2.89B 189B 3B 8.09B 102B 7.59B 7.43B 322B P/E 2026 *
63x
P/E 2027 * 39.8x
Enterprise Value 19.91B 1.97B 1.79B 1.65B 1.49B 2.81B 184B 2.92B 7.88B 99.34B 7.39B 7.24B 314B EV / Sales 2026 *
13.1x
EV / Sales 2027 * 9.71x
Free-Float
89.54%
Yield 2026 *
0.47%
Yield 2027 * 0.72%
1 day+2.26%
1 week+0.37%
Current month-1.05%
1 month+28.43%
3 months+43.83%
6 months+32.89%
Current year+71.06%
1 week 311.2
Extreme 311.2
327
1 month 246
Extreme 246
340.2
Current year 165
Extreme 165
340.2
1 year 165
Extreme 165
340.2
3 years 155
Extreme 155
405.8
5 years 34.2
Extreme 34.2
405.8
10 years 9.04
Extreme 9.04
405.8
Manager TitleAgeSince
Chief Executive Officer 49 31/08/2025
Director of Finance/CFO 63 31/10/2018
Chief Operating Officer 51 30/11/2021
Director TitleAgeSince
Director/Board Member 68 31/12/2009
Chairman 70 14/12/2016
Chairman 71 13/05/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Chief Technology Officer

-20,000 0.0304%
28/08/26 Buy

Public Communications Manager

170 0.0003%
26/08/26 Buy

Director

30 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.17%+0.37%+61.53%+96.10% 2.02B
-1.13%-1.17%+38.55%+139.23% 1,261B
-1.36%-0.74%+39.64%+86.06% 671B
-0.59%-0.36%+25.14%+111.73% 518B
-0.18%+0.95%+32.28%+71.07% 387B
-0.75%-3.16%+54.39%+40.90% 353B
-0.23%+0.23%+30.43%+57.85% 300B
-0.41%-0.88%+1.53%+36.30% 283B
-0.95%-1.57%+34.01%+72.55% 248B
+1.60%-0.36%+37.21%+125.66% 211B
Average -0.18%-0.38%+35.47%+83.75% 423B
Weighted average by Cap. -0.72%-0.55%+34.46%+95.76%

Financials

2026 *2027 *
Net sales 1.52B 150M 137M 126M 114M 215M 14.06B 223M 601M 7.59B 565M 553M 23.97B 2.02B 200M 181M 167M 151M 285M 18.65B 296M 798M 10.06B 749M 733M 31.79B
Net income 328M 32.49M 29.49M 27.24M 24.58M 46.4M 3.04B 48.17M 130M 1.64B 122M 119M 5.17B 520M 51.51M 46.76M 43.19M 38.97M 73.57M 4.81B 76.38M 206M 2.6B 193M 189M 8.2B
Net Debt -541M -53.58M -48.64M -44.93M -40.53M -76.52M -5.01B -79.45M -214M -2.7B -201M -197M -8.53B -867M -85.84M -77.93M -71.98M -64.94M -123M -8.02B -127M -343M -4.33B -322M -315M -13.67B
Projected Income Statement - Annual - Bonesupport Holding AB
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
174
Date Price Change Volume
18/11/26 SEK 321.60 +2.55% 77,766
17/11/26 SEK 313.60 -2.73% 178,785
16/11/26 SEK 322.40 +0.37% 182,942
13/11/26 SEK 321.20 +1.39% 171,865
12/11/26 SEK 316.80 -1.12% 198,333
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bonesupport Holding AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
313.60SEK
Average target price
374.67SEK
Spread / Average Target
+19.47%
  1. Stock Market
  2. Stocks
  3. BONEX Stock